SENSITIVE, HYDROSOLUBLE, MACROMOLECULAR FLUOROGENIC SUBSTRATES FOR HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEINASE

被引:6
作者
ANJUERE, F
MONSIGNY, M
LELIEVRE, Y
MAYER, R
机构
[1] CNRS,CTR BIOPHYS MOLEC,DEPT BIOCHIM GLYCOCONJUGUES & LECTINES ENDOGENES,1 RUE HAUTE,F-45071 ORLEANS 02,FRANCE
[2] UNIV ORLEANS,F-45071 ORLEANS 02,FRANCE
[3] RHONE POULENC RORER,CTR RECH VITRY ALFORTVILLE,F-94403 VITRY,FRANCE
关键词
D O I
10.1042/bj2910869
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hydrosoluble macromolecular fluorogenic substrates specific for the human immunodeficiency virus 1 (HIV-1) proteinase have been prepared. The fluoresceinyl peptide Ftc-epsilon-Ahx-Ser-Phe-Asn-Phe-Pro-Gln-Ile-Thr-(Gly)n, corresponding to the first cleavage site of HIV-1 gag-pol native precursor was linked to a water-soluble neutral (Lys)n derivative. The epsilon-aminohexanoyl residue (epsilon-Ahx) and the glycyl sequence were added in order to improve the stability of the substrate and the accessibility of the cleavage site to the HIV-1 proteinase respectively. This macromolecular peptidic-substrate conjugate is significantly more water-soluble than the free peptide itself on a substrate molar concentration basis. The assay is based on the quantitative precipitation of the polymeric material by adding propan-2-ol whereas the fluorescent peptide moiety released upon proteolysis remains soluble in the supernatant. The proteinase activity is assessed by measuring the fluorescence of the supernatant. This assay allows the detection of a few fmol of HIV-1 proteinase, even in the presence of cell culture media, plasma or cell lysate and it gives accurate results within a large proteinase concentration range. The hydrosoluble macromolecular substrate is also suitable for determining the HIV-1 proteinase activity using 96-well microplates, allowing us to test accurately and rapidly numerous enzyme samples and/or the potency of new proteinase inhibitors.
引用
收藏
页码:869 / 873
页数:5
相关论文
共 23 条
[1]   WATER-SOLUBLE MACROMOLECULAR FLUOROGENIC SUBSTRATES FOR ASSAYING PROTEINASES - DETERMINATION OF PANCREATIC ELASTASE ACTIVITY [J].
ANJUERE, F ;
MONSIGNY, M ;
MAYER, R .
ANALYTICAL BIOCHEMISTRY, 1991, 198 (02) :342-346
[2]   TIGHT-BINDING INHIBITORS .1. KINETIC-BEHAVIOR [J].
CHA, S .
BIOCHEMICAL PHARMACOLOGY, 1975, 24 (23) :2177-2185
[3]   HIV-1 PROTEASE SPECIFICITY OF PEPTIDE CLEAVAGE IS SUFFICIENT FOR PROCESSING OF GAG AND POL POLYPROTEINS [J].
DARKE, PL ;
NUTT, RF ;
BRADY, SF ;
GARSKY, VM ;
CICCARONE, TM ;
LEU, CT ;
LUMMA, PK ;
FREIDINGER, RM ;
VEBER, DF ;
SIGAL, IS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 156 (01) :297-303
[4]   MURAMYL DIPEPTIDE BOUND TO POLY-L-LYSINE SUBSTITUTED WITH MANNOSE AND GLUCONOYL RESIDUES AS MACROPHAGE ACTIVATORS [J].
DERRIEN, D ;
MIDOUX, P ;
PETIT, C ;
NEGRE, E ;
MAYER, R ;
MONSIGNY, M ;
ROCHE, AC .
GLYCOCONJUGATE JOURNAL, 1989, 6 (02) :241-255
[5]   FLUORESCENCE-BASED CONTINUOUS ASSAY FOR THE ASPARTYL PROTEASE OF HUMAN IMMUNODEFICIENCY VIRUS-1 [J].
GEOGHEGAN, KF ;
SPENCER, RW ;
DANLEY, DE ;
CONTILLO, LG ;
ANDREWS, GC .
FEBS LETTERS, 1990, 262 (01) :119-122
[6]   HIV-1 aspartic proteinase: high-level production and automated fluorometric screening assay of inhibitors [J].
Hirel, Ph-H ;
Parker, F. ;
Boiziau, J. ;
Jung, G. ;
Outerovitch, D. ;
Dugue, A. ;
Peltiers, C. ;
Giuliacci, C. ;
Boulay, R. ;
Lelievre, Y. ;
Cambou, B. ;
Mayaux, J-F ;
Cartwright, T. .
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1990, 1 (01) :9-15
[7]   A RADIOMETRIC ASSAY FOR HIV-1 PROTEASE [J].
HYLAND, LJ ;
DAYTON, BD ;
MOORE, ML ;
SHU, AYL ;
HEYS, JR ;
MEEK, TD .
ANALYTICAL BIOCHEMISTRY, 1990, 188 (02) :408-415
[8]   INHIBITION OF RETROVIRAL PROTEASE ACTIVITY BY AN ASPARTYL PROTEINASE-INHIBITOR [J].
KATOH, I ;
YASUNAGA, T ;
IKAWA, Y ;
YOSHINAKA, Y .
NATURE, 1987, 329 (6140) :654-656
[9]   ACTIVE HUMAN IMMUNODEFICIENCY VIRUS PROTEASE IS REQUIRED FOR VIRAL INFECTIVITY [J].
KOHL, NE ;
EMINI, EA ;
SCHLEIF, WA ;
DAVIS, LJ ;
HEIMBACH, JC ;
DIXON, RAF ;
SCOLNICK, EM ;
SIGAL, IS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) :4686-4690
[10]   STANDARDIZED AND SIMPLIFIED NOMENCLATURE FOR PROTEINS COMMON TO ALL RETROVIRUSES [J].
LEIS, J ;
BALTIMORE, D ;
BISHOP, JM ;
COFFIN, J ;
FLEISSNER, E ;
GOFF, SP ;
OROSZLAN, S ;
ROBINSON, H ;
SKALKA, AM ;
TEMIN, HM ;
VOGT, V .
JOURNAL OF VIROLOGY, 1988, 62 (05) :1808-1809